A) less than 65%
B) less than 55%
C) less than 35%
D) less than 25%
Correct Answer
verified
Multiple Choice
A) Doses are usually smaller.
B) Onset of drug action is rapid.
C) Delivered dose is consistent with each administration.
D) Systemic side effects are often fewer and less severe.
Correct Answer
verified
Multiple Choice
A) pharmaceutical
B) pharmacognosy
C) pharmacokinetic
D) pharmacodynamic
Correct Answer
verified
Multiple Choice
A) albuterol
B) isoetharine
C) terbutaline
D) metaproterenol
Correct Answer
verified
Multiple Choice
A) II, III, and IV
B) II, V, and VI
C) I, III, V, and VI
D) I, II, III, and IV
Correct Answer
verified
Multiple Choice
A) albuterol
B) levalbuterol
C) terbutaline
D) bitolterol
Correct Answer
verified
Multiple Choice
A) treatment of excessive, viscous mucus secretions
B) antiinflammatory treatment of mild to moderate persistent asthma
C) treatment of reversible airflow obstruction
D) prophylactic management of asthma
Correct Answer
verified
Multiple Choice
A) breaking down DNA
B) increasing the osmolarity of the mucus and pulling water into it
C) changing the pH of the mucus, causing it to break down
D) substituting its sulfhydryl group for disulfide bonds and breaking a portion of the bond forming the gel structure
Correct Answer
verified
Multiple Choice
A) tachycardia
B) blood pressure increase
C) cough and dry mouth
D) tolerance
Correct Answer
verified
Multiple Choice
A) I and III only
B) I, II, and III
C) II, III, and IV
D) I, II, III, and IV
Correct Answer
verified
Multiple Choice
A) cromolyn-like agents
B) leukotriene modifiers
C) anti-IgE agents
D) anti-IgA agents
Correct Answer
verified
Multiple Choice
A) I and II only
B) III and IV only
C) I, III, and IV
D) I, II, III, and IV
Correct Answer
verified
Multiple Choice
A) chronic bronchitis
B) emphysema
C) asthma
D) chronic obstructive pulmonary disease (COPD)
Correct Answer
verified
Multiple Choice
A) pharmaceutical
B) pharmacognosy
C) pharmacokinetic
D) pharmacodynamic
Correct Answer
verified
Multiple Choice
A) inhaled corticosteroids
B) adrenergic bronchodilators
C) mucus-controlling agents
D) anticholinergic bronchodilators
Correct Answer
verified
Multiple Choice
A) produces antiinflammatory enzymes within cells
B) inhibits degranulation of mast cells
C) prevents arachidonic acid formation from activation of mast cell membrane phospholipase A2
D) provides leukotriene inhibition
Correct Answer
verified
Multiple Choice
A) Humulin
B) Exubera
C) Glucomax
D) No inhaled insulin has yet been approved.
Correct Answer
verified
Multiple Choice
A) I and III
B) I, II, and III
C) II, III, and IV
D) I, II, III, and IV
Correct Answer
verified
Multiple Choice
A) 1 to 3 hours
B) 3 to 5 hours
C) 5 to 7 hours
D) longer than 12 hours
Correct Answer
verified
Multiple Choice
A) I and III
B) I, III, and IV
C) II, III, and IV
D) I, II, III, and IV
Correct Answer
verified
Showing 41 - 60 of 76
Related Exams